Skip to main content

Table 3 Estimations of outpatient care costs for children with and without adverse events during RICP

From: Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)

Medical resources

Patients with AEs (n = 7)

Patients without AEs (n = 6)

Mean difference

p-value

Laboratory test, mean (SD)

$23.13 ($61.20)

$14.55 ($35.65)

$8.58

1.000a

Blood products, mean (SD)

$3.87 ($10.25)

$0.00 ($0.00)

$3.87

0.354a

Outpatient medical consultation, mean (SD)

$82.03 ($24.06)

$69.30 ($41.06)

$12.73

0.422a

Chemotherapy (RICP), mean (SD)

$4,893.91 ($1,630.34)

$2,788.57 ($1,315.28)

$2,105.34

0.032a

Total, mean (SD)

$5,002.95 ($1,589.53)

$2,872.42 ($1,340.27)

$2,130.53

0.032a

  1. SD Standard deviation, AEs Adverse events
  2. aWilcoxon rank-sum test